| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f72abc68effbbdeb55051ef9ad98593b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2858411320fb0a2e0a846742666185f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-20 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-20 |
| filingDate |
1985-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5979d20e67384e7a517dacd6313133e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ed4e0b618156b6276d885c4e1e516c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7431772fde4d5fe2158fa0cd8cd9d1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6716f4c0cd585441ec80efc22d5d340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceea09c7b867782e8dd175bf822fcdaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b3ee3efb92e44e74e4189d8f8d21b2 |
| publicationDate |
1986-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8602098-A1 |
| titleOfInvention |
Anti-leishmania monoclonal antibodies, hybridomas secreting said antibodies, antigens of leishmania recognized by said antibodies, method for obtaining them and applications of said monoclonal antibodies and said antigens |
| abstract |
The invention relates to hybridomas producing anti-Leishmania monoclonal antibodies which are characterized by their capacity to inhibit the infection of sarcomateous cells by the promastigote forms of one or a plurality of Leishmania species when those sarcomateous cells are contacted with said promastigote forms pre-incubated with the monoclonal antibodies under conditions which, in the absence of said monoclonal antibodies, would result in a high parasitemy in said cells. These monoclonal antibodies and the proteins of parasites which they recognize may be used in operations for detecting leishmanioses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2705358-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0679259-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0679259-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2619220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1458403-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2612779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0293827-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0293827-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1458403-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0288388-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9426899-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7317094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2615103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8901045-A1 |
| priorityDate |
1984-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |